You are here : Home >About us  >Board of Directors

Board of Directors 

In addition to Dr. Apte, Dr. Martin and Mr. Washington from the management, the following esteemed individuals also serve on ImmunoScience's board.

MGen John S. Grinalds USMC (Ret) – Chairman of the Board

In 1997 Major General John Grinalds was named president of The Citadel, The Military College of South Carolina, where he served until retirement in 2005. During his tenure the college successfully transitioned to coeducation in the traditionally male Corps of Cadets. Under his leadership, The Citadel also established milestones in fundraising, academics, facilities, admissions, public relations and, most importantly, reinforcing principled leadership as the premier objective of a Citadel education. Before going to The Citadel, Gen. Grinalds served for six years as headmaster of Woodberry Forest School in Virginia, a prestigious boys’ college preparatory boarding school. During that time the school made significant progress in admissions, college placement, the arts, fundraising and facilities expansion.

Gen. Grinalds retired from active military duty in 1991 after 32 years of military service, including command at platoon, company, battalion, and regimental levels, culminating in command of the Marine Corps Recruit Depot/Western Recruiting Region San Diego. He was responsible for recruiting and basic training of all Marines enlisted west of the Mississippi River.

Gen. Grinalds currently serves on the Board of Directors for Mid-America Apartment Communities, Inc. (REIT) and Carolina First Bank of the South Financial Group. His education includes a B.S., with honors, U. S. Military Academy; a B.A. Honors, M.A., Oxford University (Rhodes Scholar); and an M.B.A., with honors, Harvard Business School.

Dr. Christina Carnegie, MD

Dr. Christina Carnegie was introduced to ImmunoScience when she was asked to review our vaccine approach by an individual working with Bob Nagy's funding contact. A senior pharmaceutical physician with 20 plus years in the healthcare industry, she very quickly recognized the unique and effective approach developed by Dr. Apte. She was the catalyst that convinced our lead investor that Contre Vir is the very likely, long awaited cure for HIV / AIDS.

Dr. Carnegie is currently Director of Christina Carnegie Consultancy Ltd., consulting with UK and US companies for clinical development and product registration. Prior to forming her own company in 2000, she was employed with Abbot Laboratories Ltd., UK as Medical Director. She was responsible for clinical research operations in Great Britain and Ireland, which involved the design, execution, analysis and reporting of more than 100 clinical trials in the areas of anesthesia and intensive care, pediatric medicine, urology, cardiovascular and infectious disease, clinical nutrition and medical devices. She was extensively involved in the design and management of Phase I, II, and III clinical trials, as well as post marketing surveillance of drugs in major therapeutic areas.

Dr. Carnegie has over 20 years experience working in close liaison with the MHRA in the UK, EMEA in Europe and the FDA in the US. Additionally, she had direct responsibility for Abbot's Medical and Regulatory functions in the UK, including the management of 30 direct reports as well as an extensive number of contract Clinical Research Associates. She was a member of the UK Board of Management and worked closely with Abbot's Manufacturing and Quality Assurance Divisions, as well as with the medical and scientific community. She served as a member of the Medical Committee of The Association of the British Pharmaceutical Industry for seven years. In that capacity she actively influenced both UK and European legislation particularly with respect to clinical trial directives and pharmacovigilance. Prior to Abbot, Dr. Carnegie's previous appointments were with the NHS included Registrar Anaesthetics and Intensive Care at St. Bartholwme's Hospital, London, and Senior House Officer Anaesthetics, Guy's Hospital, London.

Dr. Carnegie is a graduate of Le Torrent, Chateau D'oex in Switzerland and the King's College Hospital Medical School. Her qualifications include MB, BS; FP Cert.; Primary FFARCS; and FFPM. Her membership in professional bodies includes the General Medical Council, Member of the Royal Society of Medicine, Member of the British Association of Pharmaceutical Physicians, and Member of the Society of Pharmaceutical Physicians.

J. Kermit Birchfield, Esq.

Mr. J. Kermit Birchfield has served on the ImmunoScience board since 2009. He is a lawyer by training, having spent 13 years on Wall Street with Shearman & Sterling LLC and Holtzmann Wise & Shepard, practicing in the areas of corporate finance and mergers and acquisitions before becoming Senior Vice President and General Counsel at Georgia-Pacific Corporation. He then was Senior Vice President and General Counsel at M/A-Com, Inc. Mr. Birchfield currently serves as Chairman of the MFS Compass Group of Funds, a $7 billion mutual fund. As well, he is an independent Director of Juridica Investments Limited, an offshore investment fund; Intermountain Industries, Inc., a holding company involved in the oil and gas industry; SiteWatch Technologies, LLC, a monitoring company for underground storage tanks; and Dessin Fournir Inc., a maker of fine furniture and fabrics for interior designers.

Mr. Birchfield spent seven years flying with the Air Force, including a year combat tour in Vietnam, and exited military service with the rank of Captain. After his Air Force service, he graduated cum laude from Roanoke College in 1968. He then graduated from the University of Virginia School of Law and went on to practice law in New York. Mr. Birchfield has also been Chairman of Charles P Young, Co., a financial printing company, and Chairman of Dairy Mart Convenience Stores, Inc.

Mr. Birchfield has been involved in many community and civic activities. He currently serves on the Board of Directors of the Cape Ann Museum.

Richard W. Fields

Mr. Fields has been a partner in several major US law firms, practicing as a corporate plaintiff’s lawyer in the areas of complex litigation and dispute resolution. While in private practice he focused on insurance coverage and contract issues, complex business dispute resolution and human rights issues. Over the course of his career Mr. Fields recovered several billion dollars for numerous Fortune 500 clients.

Described by the Legal Times of Washington, D.C. as "a master negotiator”, he has been named one of “the Leading Litigators in America” by Lawdragon Magazine, one of “America’s Leading Lawyers for Business” by Chambers, and one of “the world’s leading IP strategists” by Intellectual Asset Management.

Mr. Fields is admitted to practice in New York and the District of Columbia. He graduated from Indiana University, B.A., 1977, Phi Beta Kappa, and from Indiana University School of Law – Indianapolis, J.D., 1982, summa cum laude. He is an active member of the New York Bar Association, the Bar of the City of New York, the District of Columbia Bar, the American Bar Association and the International Bar Association. He is a member of the Board of Overseers of the Rand Corporation’s Institute for Civil Justice, a member of the Board of Visitors, Indiana University School of Law – Indianapolis, and Co-Chair of the New York Committee, Human Rights Watch.

Hiten Y. Davé

Mr. Davé is a registered physical therapist and President and CEO of Pleasanton Physical Therapy Services, Inc. and Back on Track Physical Therapy. He has operated the businesses for over 22 years. He has a BS in Physical Therapy from Northwestern University Medical School and has attended numerous continuing education programs in physical therapy. Prior to deciding on a career in physical therapy, Mr. Davé obtained a degree in microbiology and chemistry, and was pursuing a career in computer science. An auto accident resulting in a broken arm, a bone that did not set properly, corrective surgery and subsequent physical therapy convinced Mr. Davé that his life work would be in that area. His driving passion is being able to help his patients return to as normal a life as possible. In one news article he was quoted as saying "I want to empower patients so they can function better on their own and avoid the cycle of feeling pain, feeling good for a while and feeling pain again."

Mr. Davé was an early investor, actually providing funding for the first clinical trial in India prior to the incorporation of ImmunoScience. With his background in microbiology he understood the efficacy of the approach taken by Dr. Sateesh Apté, as well quickly understanding the opportunity to not only save many lives but to significantly improve the quality of life for many people around the world. In addition to being an early investor, Mr. Davé was a conduit for a number of other investors, and was the one responsible for the Company being able to literally keep its doors open on several occasions. He has been key in the progress to date.

Thomas S. Snyder, MBA

Mr. Thomas Snyder brings financial and management experience to the ImmunoScience, Inc. Board of Directors. Presently, Mr. Snyder is President/Owner of Cedar Valley Homes, a residential subdivision development and home construction company (since 2003). Prior to that, Mr. Snyder was President of LMCB Financial Services, where he provided business consulting services primarily in the origination of capital for early stage development companies. He assisted in successfully raising over $35 million for such ventures. From 1992 to 1999 he was Director of the Columbus office of the University of Georgia Small Business Development Center, where he was also a lead instructor on business start-ups and also provided consulting services on finance and capital formation. He was Director of Practice Management for Columbus Regional Healthcare System, where he was responsible for physician recruitment and managing ten physician practices. Mr. Snyder was the owner and manager of a multi-unit, multi-state garden and landscaping business for 12 years. He also served as a Senior Financial Analyst with Baxtor-Travenol after serving as a budget and supply officer with the US Navy from 1968 to 1971, with postings in Vietnam. Mr. Snyder graduated from Princeton University with a BA in US History (cum laude) and earned an MBA from Harvard University.